RecruitingNot ApplicableNCT06924801

Integration of Real-Time Motion Tracking and Pediatric Rehabilitation

Evaluating the Feasibility, Usability, and Integration of the OptiTrack Motion Capture System in Inpatient Physical Therapy


Sponsor

Stanford University

Enrollment

30 participants

Start Date

Oct 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Emerging technologies that utilize motion capture integrated with engaging software offer new methods for increasing engagement and movement in patients admitted to the hospital. Hospitalized patients are often limited to sedentary activities, spending the majority of their time in bed, which can contribute to deconditioning and functional mobility deficits. This study seeks to explore the feasibility of a tool designed to promote movement through engaging gameplay that is acceptable to both clinicians and families.


Eligibility

Min Age: 6 YearsMax Age: 17 Years

Inclusion Criteria4

  • Pediatric patients aged 6-17 years.
  • Receiving physical therapy at Stanford Children's Hospital.
  • Medically cleared for standing and upper-body movement.
  • Ability to follow simple instructions and engage in standing gameplay

Exclusion Criteria5

  • Orthopedic or medical conditions contraindicating physical activity.
  • Legal guardian not present to obtain consent
  • Child with a significant neurological condition or major developmental disability
  • Child with active infection of the face or hand
  • A history of severe motion sickness A history of seizures caused by flashing light Major surgery within the last 48 hours

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSnipperfingers

Snipperfinger is a self developed engagement focused software platform designed to encourage participation in pediatric physical therapy.


Locations(1)

Lucile Packard Children's Hospital Stanford

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06924801


Related Trials